124 related articles for article (PubMed ID: 36736869)
1. A novel bidirectional perfusion-like administered system for NIR-II fluorescence imaging precision diagnosis of bladder cancer.
Ren S; Dai R; Zheng Z; Liu Q; Zheng X; Li J; Wu S; Zhang R; Gui Z
Nanomedicine; 2023 Apr; 49():102661. PubMed ID: 36736869
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Optical Imaging of Bladder Cancer Tissues in an MB49 Bladder Cancer Orthotopic Mouse Model Using the Intravesical or Intravenous Administration of Near-Infrared Fluorescence Probe.
Teranishi K
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768680
[TBL] [Abstract][Full Text] [Related]
3. [Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].
Ding XL; Yang DL; Yan RP; Li ZP; Ye CW; He J; Yu L; He SC; Li HD
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):308-312. PubMed ID: 29730921
[No Abstract] [Full Text] [Related]
4. Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model.
Bachor R; Flotte TJ; Scholz M; Dretler S; Hasan T
J Urol; 1992 May; 147(5):1404-10. PubMed ID: 1569696
[TBL] [Abstract][Full Text] [Related]
5. Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel.
Yoon HY; Chang IH; Goo YT; Kim CH; Kang TH; Kim SY; Lee SJ; Song SH; Whang YM; Choi YW
Int J Nanomedicine; 2019; 14():6249-6268. PubMed ID: 31496684
[TBL] [Abstract][Full Text] [Related]
6. Current status of the development of intravesical drug delivery systems for the treatment of bladder cancer.
Yoon HY; Yang HM; Kim CH; Goo YT; Kang MJ; Lee S; Choi YW
Expert Opin Drug Deliv; 2020 Nov; 17(11):1555-1572. PubMed ID: 32791923
[TBL] [Abstract][Full Text] [Related]
7. Tumor localization and systemic absorption of intravesical instillation of radio-iodinated iododeoxyuridine in patients with bladder cancer.
Chiou RK; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Harrison KA; Taylor RJ
J Urol; 1999 Jul; 162(1):58-62. PubMed ID: 10379740
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of intravesical instillation of pirarubicin for preventing recurrence of non-muscle invasive bladder cancer].
Li Q; Xu T; Wang XF
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):904-7. PubMed ID: 20193328
[TBL] [Abstract][Full Text] [Related]
9. The value of immediate postoperative intravesical epirubicin instillation as an adjunct to standard adjuvant treatment in intermediate and high-risk non-muscle-invasive bladder cancer: A preliminary results of randomized controlled trial.
Elsawy AA; El-Assmy AM; Bazeed MA; Ali-El-Dein B
Urol Oncol; 2019 Mar; 37(3):179.e9-179.e18. PubMed ID: 30448030
[TBL] [Abstract][Full Text] [Related]
10. Clinical application of drug sensitive gene detection in postoperative instillation for non-muscle invasive bladder cancer.
Wang Z; Tang H; Xue Y; Xue L; Li H; Chong T
BMC Nephrol; 2020 Oct; 21(1):426. PubMed ID: 33028224
[TBL] [Abstract][Full Text] [Related]
11. Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer.
Racioppi M; Di Gianfrancesco L; Ragonese M; Palermo G; Sacco E; Bassi P
Eur Urol Oncol; 2019 Sep; 2(5):576-583. PubMed ID: 31411974
[TBL] [Abstract][Full Text] [Related]
12. PET/NIR-II fluorescence imaging and image-guided surgery of glioblastoma using a folate receptor α-targeted dual-modal nanoprobe.
Shi X; Xu P; Cao C; Cheng Z; Tian J; Hu Z
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4325-4337. PubMed ID: 35838757
[TBL] [Abstract][Full Text] [Related]
13. [The intravesical recurrence after 3-day consecutive intravesical instillation of pirarubicine hydrochloride (THP) following transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer].
Tochigi T; Sakurada Y; Aoki H; Kawamura S; Itou S; Satou I; Tateno H
Nihon Hinyokika Gakkai Zasshi; 2012 Jul; 103(4):610-6. PubMed ID: 23120995
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Retention Microbubbles with Three-Layer Structure for Floating Intravesical Instillation Delivery.
Deng Q; Xie J; Kong S; Tang T; Zhou J
Small; 2023 Apr; 19(14):e2205630. PubMed ID: 36634975
[TBL] [Abstract][Full Text] [Related]
15. Fluorinated Chitosan To Enhance Transmucosal Delivery of Sonosensitizer-Conjugated Catalase for Sonodynamic Bladder Cancer Treatment Post-intravesical Instillation.
Li G; Wang S; Deng D; Xiao Z; Dong Z; Wang Z; Lei Q; Gao S; Huang G; Zhang E; Zeng G; Wen Z; Wu S; Liu Z
ACS Nano; 2020 Feb; 14(2):1586-1599. PubMed ID: 32011860
[TBL] [Abstract][Full Text] [Related]
16. [Appropriate intravesical retention time of pirarubicin concentration based on its level in tumor tissue, anti-tumor effect and side effect in intravesical instillation therapy for bladder tumor].
Kobayashi M; Sugaya Y; Yuzawa M; Ochi M; Morita T; Kobayashi Y; Tokue A; Hara Y
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1771-4. PubMed ID: 9757205
[TBL] [Abstract][Full Text] [Related]
17. Whole bladder photodynamic therapy for orthotopic superficial bladder cancer in rats: a study of intravenous and intravesical administration of photosensitizers.
Xiao Z; Brown K; Tulip J; Moore RB
J Urol; 2003 Jan; 169(1):352-6. PubMed ID: 12478188
[TBL] [Abstract][Full Text] [Related]
18. In vivo biodistribution and toxicity of intravesical administration of quantum dots for optical molecular imaging of bladder cancer.
Pan Y; Chang T; Marcq G; Liu C; Kiss B; Rouse R; Mach KE; Cheng Z; Liao JC
Sci Rep; 2017 Aug; 7(1):9309. PubMed ID: 28839158
[TBL] [Abstract][Full Text] [Related]
19. NIR-II-triggered doxorubicin release for orthotopic bladder cancer chemo-photothermal therapy.
Sun Z; Zhang W; Ye Z; Yuan L; Fu M; Liu X; Liang H; Han H
Nanoscale; 2022 Dec; 14(48):17929-17939. PubMed ID: 36325926
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of retention time of intravesical instillation therapy with pirarubicin (THP)].
Sugano O; Shoji N; Hatakeyama T; Kato H
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1169-74. PubMed ID: 8751805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
